Apimeds Pharmaceuticals US (APUS) P/B (2025 - 2026)
Apimeds Pharmaceuticals US (APUS) P/B from May 9, 2025 to Jul 20, 2026. The TTM Apimeds Pharmaceuticals US (APUS) P/B is 0.06. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Apimeds Pharmaceuticals US (APUS)
| Year | P/B | Change |
|---|---|---|
| 2026 | 0.06 | -53.07% |
| 2025 | 0.13 | N/A |
Comparison Apimeds Pharmaceuticals US (APUS) P/B with competitors
Apimeds Pharmaceuticals US (APUS) P/B is 0.06.